Singapore markets open in 6 hours 6 minutes
Straits Times Index
3,332.80 -10.55 (-0.32%) S&P 500
5,460.48 -22.39 (-0.41%) Dow
39,118.86 -45.24 (-0.12%) Nasdaq
17,732.60 -126.10 (-0.71%) Bitcoin USD
61,856.76 +950.74 (+1.56%) CMC Crypto 200
1,281.02 -2.81 (-0.22%)
BioLineRx Ltd. (YP2A.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 09:24AM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 45.57M |
| Enterprise value | 29.83M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.22 |
| Price/book (mrq) | 3.17 |
| Enterprise value/revenue | 2.74 |
| Enterprise value/EBITDA | 0.39 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.93 |
| 52-week change 3 | -66.39% |
| S&P500 52-week change 3 | 22.55% |
| 52-week high 3 | 2.3800 |
| 52-week low 3 | 0.4740 |
| 50-day moving average 3 | 0.5620 |
| 200-day moving average 3 | 1.0664 |
Share statistics
| Avg vol (3-month) 3 | N/A |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 79.94M |
| Implied shares outstanding 6 | 80.36M |
| Float 8 | 989.89M |
| % held by insiders 1 | 8.54% |
| % held by institutions 1 | 1.75% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:15 |
| Last split date 3 | 15 Jul 2019 |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -70.34% |
Management effectiveness
| Return on assets (ttm) | -40.50% |
| Return on equity (ttm) | -188.40% |
Income statement
| Revenue (ttm) | 11.65M |
| Revenue per share (ttm) | 0.18 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -37.5M |
| Net income avi to common (ttm) | -49.15M |
| Diluted EPS (ttm) | -0.7100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 28.17M |
| Total cash per share (mrq) | 0.03 |
| Total debt (mrq) | 11.31M |
| Total debt/equity (mrq) | 86.63% |
| Current ratio (mrq) | 1.49 |
| Book value per share (mrq) | 0.01 |
Cash flow statement
| Operating cash flow (ttm) | -28.7M |
| Levered free cash flow (ttm) | -17.29M |
© 2024 Yahoo. All rights reserved.